By Gina Kolata The blockbuster drug semaglutide, sold as Ozempic for diabetes and as Wegovy for weight loss, now has a new ...

The results of a clinical trial published this week found that the active ingredient in the diabetes and weight loss medications Ozempic and Wegovy was linked with a near halving of reported pain ...

Semaglutide (Wegovy) reduced pain and improved physical function in patients with obesity and knee osteoarthritis, a ...

To help reduce pain and slow joint damage, focus on eating more anti-inflammatory foods and limit those that may promote ...

Novo Nordisk's (NVO) semaglutide, marketed as Wegovy for obesity, shows promise in reducing joint disease symptoms in ...

Weight reduction has been shown to alleviate symptoms of osteoarthritis of the knee, including pain. The effect of ...

Metabolic syndrome and its individuals components may contribute to the progression of knee OA among both men and women, largely due to high BMI.

A recent study published in the New England Journal of Medicine highlights that the weight loss drugs Ozempic and Wegovy, ...

For individuals with obesity and knee osteoarthritis, once-weekly semaglutide yields greater reductions in body weight and ...

Total hip replacement is routinely recommended for severe hip osteoarthritis, but data from randomized trials are lacking ...

The current state of canine osteoarthritis management, and early diagnosis with COAST, were covered during a lecture at the ...

Osteoarthritis, the most common form of arthritis, is primarily caused by wear and tear on the protective layer of cartilage ...